Syndax Pharmaceuticals Inc (SNDX)
Free Cash Flow Growth
65.47%
Quarterly · Period ending:
SNDX Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported65.47%period ending
Latest reported65.47%period ending
SNDX Quarterly Free Cash Flow YoY % (-261496.24% → 65.47%)
Year-over-year change
High-resolution chart · PNG
SNDX free cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow Growth |
|---|---|
| 65.4741% | |
| 47.0955% | |
| -21.1821% | |
| -13.3885% | |
| -22.5417% | |
| -13.901% | |
| -38.7893% | |
| -39.5696% | |
| -102.5529% | |
| -112.9805% | |
| -80.6106% | |
| -56.4357% | |
| 12.2438% | |
| 6.4463% | |
| -122.762% | |
| -14.4323% | |
| -67.6274% | |
| -85.6257% | |
| 743.4649% | |
| -36.3284% | |
| -12.3231% | |
| -41.8462% | |
| -22.8176% | |
| -114.5269% | |
| -70.9142% | |
| 5.3829% | |
| 15.4745% | |
| 53.8199% | |
| 17.3213% | |
| 16.0255% | |
| -17.9646% | |
| -80.6613% | |
| -28.3814% | |
| -58.2176% | |
| -22.5422% | |
| 11.1275% | |
| -69.4672% | |
| -93.8188% | |
| -140.7767% | |
| -121.4244% | |
| -74.0315% | |
| -159.1761% | |
| -24.3461% | |
| -99.6541% | |
| -5.1788% | |
| 344.7917% | |
| -24.8744% | |
| -21.8735% | |
| -310.356% | |
| -203.8384% | |
| -261,496.2441% |